MENU
PRTA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Prothena (PRTA) Ownership - Who owns Prothena?
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
77 Sir John Rogerson’s Quay
Phone
+353 12362500
Employees
173
Web
https://www.prothena.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
653.46M
P/E Ratio
N/A
Total Cash
471.39M
Projected Growth
N/A
Total Debt
10.84M
Revenue
135.16M
Risk (Beta)
-0.83
Dividend Yield
N/A
Total Cash/Share
8.76
Total Debt/Equity
N/A
Revenue/Share
2.51 USD as % of share price
Fundamentals
PRTA
Capitalization
653M
P/E Ratio
N/A
Risk (Beta)
-0.83
Dividend Yield
N/A
Total Cash
471M
Total Cash/Share
8.76
Total Debt
10.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.51%
Revenue
135M
ROE
N/A
Book Value
487M
P/B Ratio
1.34
Cash Flow
N/A
Earnings
-2.27
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
538K
Current Ratio
10.01
Current Revenue Per Employee
13024.54
Dividends Per Share - Security
N/A
EBITDA
-153.67M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-19.67
Shares Held By Institutions
2.36B
Shares Outstanding - Current
53.8M
Total Liabilities
60.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-12.347
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel antibodies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
77 Sir John Rogerson’s Quay
Phone
+353 12362500
Employees
173
Web
https://www.prothena.com